article thumbnail

Pneumococcal Vaccine Rates Low Despite Updated Recommendations

Drug Topics

A team of investigators from Avalere Health and Pfizer conducted a study to assess uptake of pneumococcal vaccine recommendations and disparities in uptake across subgroups of adult patients. The retrospective cohort study gathered data from the Optum de-identified Clinformatics Data Mart Database from January 2015 through October 2023.

Vaccines 342
article thumbnail

Results Find SGLT2 Inhibitors Associated With Erythrocytosis

Drug Topics

Investigators included patients who initiated SGLT2is or a comparator, including GLP-1s or dipeptidyl peptidase 4 inhibitors (DPP-4i). Patients were 18 years and older with type 2 diabetes and were included from January 1, 2015, through June 30, 2024. Sign up today for our free Drug Topics newsletter. REFERENCES 1.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A decade of driving medicines optimisation innovation in clinical pharmacy

Hospital Pharmacy Europe

This was achieved through an innovation and change programme that involved collaboration among multidisciplinary professionals and patients. SIMPATHY The Stimulating Innovation Management of Polypharmacy and Adherence in THe ElderlY ( SIMPATHY ) project ran from 1 June 2015 to 31 May 2017. 7 March 2024 [Accessed April 2025].

article thumbnail

Understanding Biologics and Biosimilars Amid an Evolving Treatment Landscape

Pharmacy Times

billion worth in savings in 2023 and $36 billion since the first biosimilar entered the market in 2015. Of note, the significant cost savings achieved through biosimilars underscore their economic importance in increasing patient access to life-altering medications. It is estimated that there was approximately $12.4 REFERENCE Darkow A.

article thumbnail

Correct Patient Misconceptions Around Biosimilars

Pharmacy Times

Pharmacists stand at the forefront of patient care, making them indispensable in dispelling misinformation that can sometimes surround biosimilars. Their accessibility and expertise perfectly position them to engage in direct conversations with patients, addressing safety, efficacy, and interchangeability concerns. April 2015.

article thumbnail

Overdose Deaths Begin to Sustain Decline After Decades Long Increase

Drug Topics

Death rates were collected from January 2015 to October 2024, and geographic regions—Midwest, Northeast, South, and West—were used. 1 Investigators found that 800,645 patients died from a drug overdose in the time period, with 31.7% per 100,000 population in January 2015 to a peak of 33.24 From 2018 through 2024, 1.4%

article thumbnail

From data to impact: How real-world evidence will transform healthcare

pharmaphorum

Skip to main content Monday 7 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)